Journal of Shandong University (Health Sciences) ›› 2021, Vol. 59 ›› Issue (10): 59-69.doi: 10.6040/j.issn.1671-7554.0.2021.0367
Previous Articles Next Articles
DU Tiantian1,2, LI Juan1,2, ZHAO Yinghui1,2, DUAN Weili1,2, WANG Jing1,2, WANG Yunshan1,2, DU Lutao1,2, WANG Chuanxin1,2
CLC Number:
[1] Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70(3): 145-164. [2] Willauer AN, Liu Y, Pereira AAL, et al. Clinical and molecular characterization of early-onset colorectal cancer[J]. Cancer, 2019, 125(12): 2002-2010. [3] Steffen P, Li J, Chandra J, et al. Molecular features of lymph node metastasis in T1/2 colorectal cancer from formalin-fixed paraffin-embedded archival specimens[J]. J Proteome Res, 2021, 20(2): 1304-1312. [4] Burnett-Hartman AN, Lee JK, Demb J, et al. An update on the epidemiology, molecular characterization, diagnosis, and screening strategies for early-onset colorectal cancer[J]. Gastroenterology, 2021, 160(4): 1041-1049. [5] Meng N, Chen M, Chen D, et al. Small protein hidden in lncRNA LOC90024 promotes "cancerous" RNA splicing and tumorigenesis[J]. Adv Sci(Weinh), 2020, 7(10): 1903233. doi: 1903210.1901002/advs.201903233. [6] Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs[J]. Cell, 2009, 136(4): 629-641. [7] Shi X, Sun M, Liu H, et al. Long non-coding RNAs: a new frontier in the study of human diseases[J]. Cancer Lett, 2013, 339(2): 159-166. [8] Tachiwana H, Saitoh N. Nuclear long non-coding RNAs as epigenetic regulators in cancer[J]. Curr Med Chem, 2021, 28(25):5098-5109. [9] Hu A, Hong F, Li D, et al. Long non-coding RNA ROR recruits histone transmethylase MLL1 to up-regulate TIMP3 expression and promote breast cancer progression[J]. J Transl Med, 2021, 19(1): 95. doi: 10.1186/s12967-12020-02682-12965. [10] Melixetian M, Bossi D, Mihailovich M, et al. Long non-coding RNA TINCR suppresses metastatic melanoma dissemination by preventing ATF4 translation[J]. EMBO Rep, 2021, 22(3): e50852. doi: 50810.15252/embr.202050852. [11] Nam GH, Choi Y, Kim GB, et al. Emerging prospects of exosomes for cancer treatment: from conventional therapy to immunotherapy[J]. Adv Mater, 2020, 32(51): e2002440. doi: 2002410.2001002/adma.202002440. [12] Exosome profiling pinpoints cancer type[J]. Cancer Discov, 2020, 10(11): 1619. doi: 1610.1158/2159-8290.CD-NB2020-1083. [13] Khomtchouk BB, Hennessy JR, Wahlestedt C. shinyheatmap: Ultra fast low memory heatmap web interface for big data genomics[J]. PLoS One, 2017, 12(5): e0176334. doi: 0176310.0171371/journal.pone.0176334. [14] Akimoto N, Ugai T, Zhong R, et al. Rising incidence of early-onset colorectal cancer-a call to action[J]. Nat Rev Clin Oncol, 2020, 18(4): 230-243. [15] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. [16] 郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1): 19-28. [17] Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome[J]. Nature, 2001, 409(6822): 860-921. [18] Statello L, Guo CJ, Chen LL, et al. Gene regulation by long non-coding RNAs and its biological functions[J]. Nat Rev Mol Cell Biol, 2021, 22(2): 96-118. [19] Pefanis E, Wang J, Rothschild G, et al. RNA exosome-regulated long non-coding RNA transcription controls super-enhancer activity[J]. Cell, 2015, 161(4): 774-789. [20] Qu L, Ding J, Chen C, et al. Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA[J]. Cancer Cell, 2016, 29(5): 653-668. [21] Xu R, Rai A, Chen M, et al. Extracellular vesicles in cancer-implications for future improvements in cancer care[J]. Nat Rev Clin Oncol, 2018, 15(10): 617-638. [22] 常文婧, 李冬, 孙祖俊. 外泌体长链非编码RNA:肿瘤分子诊断新型标志物[J]. 国际检验医学杂志, 2020, 41: 1793-1799. [23] Guo X, Lv X, Ru Y, et al. Circulating exosomal gastric cancer-associated long noncoding RNA1 as a biomarker for early detection and monitoring progression of gastric cancer: a multiphase study[J]. JAMA Surg, 2020, 155(7): 572-579. [24] Lin LY, Yang L, Zeng Q, et al. Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer[J]. Mol Cancer, 2018, 17(1): 84. doi: 10.1186/s12943-12018-10834-12949. [25] Qi P, Zhou XY, Du X. Circulating long non-coding RNAs in cancer: current status and future perspectives[J]. Mol Cancer, 2016, 15(1): 39. doi: 10.1186/s12943-12016-10524-12944. [26] Dong L, Lin W, Qi P, et al. Circulating long RNAs in serum extracellular vesicles: their characterization and potential application as biomarkers for diagnosis of colorectal cancer[J]. Cancer Epidemiol Biomarkers Prev, 2016, 25(7): 1158-1166. [27] Zeng ZL, Lu JH, Wang Y, et al. The lncRNA XIST/miR-125b-2-3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer[J]. Cancer Med, 2021, 10(7): 2423-2441. [28] Si Z, Yu L, Jing H, et al. Oncogenic lncRNA ZNF561-AS1 is essential for colorectal cancer proliferation and survival through regulation of miR-26a-3p/miR-128-5p-SRSF6 axis[J]. J Exp Clin Cancer Res, 2021, 40(1): 78. doi: 10.1186/s13046-13021-01882-13041. [29] Wang X, Zhou J, Xu M, et al. A 15-lncRNA signature predicts survival and functions as a ceRNA in patients with colorectal cancer[J]. Cancer Manag Res, 2018, 10: 5799-5806. doi:10.2147/CMAR.S178732. [30] Qian X, Li S, Yang Z, et al. The long non-coding RNA HLNC1 potentiates hepatocellular carcinoma progression via interaction with USP49[J]. J Clin Lab Anal, 2020, 34(11): e23462. doi: 23410.21002/jcla.23462. [31] Li Y, Zeng C, Hu J, et al. Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression[J]. J Hematol Oncol, 2018, 11(1): 89. doi: 10.1186/s13045-13018-10632-13042. [32] Peng W, Zhang C, Peng J, et al. Lnc-FAM84B-4 acts as an oncogenic lncRNA by interacting with protein hnRNPK to restrain MAPK phosphatases-DUSP1 expression[J]. Cancer Lett, 2020, 494: 94-106. doi:10.1016/j.canlet.2020.08.036. [33] Luo D, Li C, Wu L, et al. Advances of exosomes extraction and its mechanism in early diagnosis of lung cancer[J]. Zhongguo Fei Ai Za Zhi, 2020, 23(11): 999-1006. |
[1] | LI Bo-Bo, LI Dao-Tang, LIU Shu-Guang, WANG Xing-Wu. Expression of serum DKK-1 in esophageal cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 58-61. |
[2] | WANG Xin, XING Chun-Yan, YANG Yan-Ping. Serum phosphopyruvate hydratase in diagnosis of invasive Candida albicans infection [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 92-94. |
[3] | LV Yan-Feng, DING Ke, WANG Jian-Xin, YU Hua-Long, BEI Shao-Sheng. Canceration of chronic anal fistula [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 55-57. |
[4] | XU Ping, YU Guo-Fang, LI Xia. Differential diagnosis of Graves′ disease and Hashimoto′s thyroiditis by different types peak systolic velocity of the superior thyroid artery [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 62-64. |
[5] | WANG Lihui, GAO Min, KONG Beihua. Angiosarcoma of the uterus: a report of 2 cases and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 108-112. |
[6] | ZHAO Ge, ZOU Cunhua, SONG Dongdong, ZHAO Shuping. Effects of tanshinone IIA on the proliferation and apoptosis of endometrial carcinoma cells [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 53-58. |
[7] | JIANG Ziqing, ZENG Yanping, JI Xiaodong, ZUO Junling. A case report of hemophagocytic syndrome secondary to talaromyces marneffei infection [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 91-97. |
[8] | ZHANG Jingliang, LIU Xinyu, YUAN Suomao, WANG Lianlei. Causes of misdiagnosis and mistreatment of lumbar degenerative diseases complicated with hip joint diseases(hip-spine syndrome) [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 67-73. |
[9] | SONG Min, ZHOU Yuxia, GAO Lu, LIU Na, WANG Ju, GU Jin, ZHANG Yanping. Prenatal diagnosis for a fetus of mosaic trisomy 6q [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 109-113. |
[10] | ZUO Liping, JIANG Fengyang, ZHOU Binbin, FAN Jinlei, LIANG Yongfeng, DENG Zhanhao, YU Dexin. Value of preoperative multiphase MRI for predicting microvascular invasion and early recurrence of 169 hepatocellular carcinoma [J]. Journal of Shandong University (Health Sciences), 2022, 60(3): 89-95. |
[11] | PAN Pengfei, XU Lisheng, JI Kunqian, WANG Dexiang, LI Yu. Mitochondrial myopathy beginning with respiratory failure: one case and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 54-59. |
[12] | SONG Yufeng, NING Hao, YAO Zhigang, WU Haihu, LIU Feifan, LYU Jiaju. Clinical and imaging features of adrenal cavernous hemangioma [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 37-42. |
[13] | ZHU Yongcun, ZHAO Xiushi, SUN Nannan, YAO Zhigang, ZHOU Xingchen, MU Kun. Prostate clear cell adenocarcinomas: a report of 3 cases and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 102-107. |
[14] | LI Xiangze, WANG Xianming, SONG Gesheng, CUI Jing, SUN Kai, WANG Haochen, WANG Tiancheng, HAN Shaoqi, TIAN Hu. Hepatic epithelioid hemangioendothelioma complicated with hepatitis B cirrhosis: a case report and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 89-95. |
[15] | CHE Guowei. It is necessary for enhanced recovery after surgery to keep pace with the times [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 17-22. |
|